Filing Details

Accession Number:
0001123292-17-000047
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-04 18:48:13
Reporting Period:
2016-12-31
Filing Date:
2017-01-04
Accepted Time:
2017-01-04 18:48:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881524 Vivus Inc VVUS Pharmaceutical Preparations (2834) 943136179
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640688 T Santosh Varghese C/O Vivus, Inc.
900 E. Hamilton Ave., Suite 550
Campbell CA 95008
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-12-31 13,426 $1.12 74,830 No 4 S Direct
Common Stock Disposition 2016-12-31 364 $1.12 74,466 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Sold to pay the tax liability resulting from the vesting of 34,200 restricted stock units granted on July 31, 2015.
  2. Sold to pay the tax liability resulting from the vesting of 919 restricted stock units granted on January 23, 2015.